Bank Of Montreal Medicenna Therapeutics Corp. Transaction History

Bank Of Montreal

  • $214 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$1.53 - $2.85 $58,221 - $108,451
-38,053 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$1.91 - $3.05 $13,746 - $21,950
-7,197 Reduced 15.9%
38,053 $101,000
Q2 2021

Aug 12, 2021
BUY
$2.97 - $4.28 $134,392 - $193,670
45,250 New
45,250 $144,000

Others Institutions Holding MDNA

# of Institutions
3
Shares Held
863K
Call Options Held
0
Put Options Held
0
View Full List

About Medicenna Therapeutics Corp.

MDNA Quotes by TradingView
  • Ticker MDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,637,504
  • Market Cap $21.6M
  • Description
  • Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as...
More about MDNA
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email